Market closedNon-fractional
Acasti Pharma/ACST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Acasti Pharma
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.
Ticker
ACST
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Princeton, United States
Employees
32
Website
www.acastipharma.com
Acasti Pharma Metrics
BasicAdvanced
$27M
Market cap
-
P/E ratio
-$1.35
EPS
1.62
Beta
-
Dividend rate
Price and volume
Market cap
$27M
Beta
1.62
Financial strength
Current ratio
14.258
Quick ratio
14.09
Management effectiveness
Return on assets (TTM)
-9.25%
Return on equity (TTM)
-19.82%
Valuation
Price to book
0.46
Price to tangible book (TTM)
2.27
Price to free cash flow (TTM)
-2.221
Growth
Earnings per share change (TTM)
-76.36%
3-year earnings per share growth
-44.67%
What the Analysts think about Acasti Pharma
Analyst Ratings
Majority rating from 1 analysts.
Acasti Pharma Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$0
NaN%
Net income
-$2.3M
-28.13%
Profit margin
0.00%
NaN%
Acasti Pharma Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q3 24
Q4 24
Actual
-$3.90
-$0.30
-
Expected
-$0.84
-$0.31
-$0.48
Surprise
364.29%
-3.40%
-
Acasti Pharma News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Acasti Pharma stock?
Acasti Pharma (ACST) has a market cap of $27M as of July 06, 2024.
What is the P/E ratio for Acasti Pharma stock?
The price to earnings (P/E) ratio for Acasti Pharma (ACST) stock is 0 as of July 06, 2024.
Does Acasti Pharma stock pay dividends?
No, Acasti Pharma (ACST) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next Acasti Pharma dividend payment date?
Acasti Pharma (ACST) stock does not pay dividends to its shareholders.
What is the beta indicator for Acasti Pharma?
Acasti Pharma (ACST) has a beta rating of 1.62. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Acasti Pharma stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.